Etcembly
AI-powered biologics discovery tools and design-ready biological assets for biotech and pharmaceutical R&D teams
Highlights
- New on EvolcAdded 2026-11-13
About Etcembly
Etcembly develops EMLy, an AI platform for biologics discovery that combines machine learning, immune datasets and computational models. It supports design and optimisation of biologics, including antibodies and TCRs, with a focus on stability, expression and manufacturability.
The company serves biotech companies and pharmaceutical R&D organisations. It also creates biological assets for partnership and licensing.
Etcembly is headquartered in Oxford, United Kingdom. The company was founded in 2019; its team has contributed to the development of more than 20 FDA-approved therapies. It reports having raised $20 million and filed four patents.
Product: EMLy, an AI platform for biologics discovery and optimisation, plus biological assets offered for partnership and licensing.
Jobs at Etcembly
More biotech & pharma companies
Evestia Clinical
Clinical research organisation providing trial management, monitoring and regulatory services to biotech sponsorsExciting Instruments
Benchtop single-molecule fluorescence instruments for academic and biopharma labs studying molecular dynamicsNew on EvolcExosla
Develops extracellular-vesicle immunotherapies for newborns with hypoxic brain injury and other immune-related diseasesNew on EvolcExtracellular
CDMO for cell-based food, cosmetics and materials products, offering bioprocess development and up to 2,000L manufacturingYoung companySalary transparentExymes
Enzyme-based DNA/RNA extraction reagents and kits for forensic, academic, veterinary and environmental labsYoung company
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WixHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Monitoring
- SentryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.